Literature DB >> 7747373

Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984-1994). Dallas Outcomes Research Group for Urological Disorders.

S E Litwiller1, B Djavan, B V Klopukh, J C Richier, C G Roehrborn.   

Abstract

OBJECTIVES: To analyze changing trends in the surgical treatment for localized carcinoma of the prostate in a large metropolitan community hospital over a 10-year period from 1984 to 1994.
METHODS: The records of all 428 patients who underwent radical prostatectomy for localized carcinoma of the prostate from January 1, 1984, to January 1, 1994, at a large metropolitan community hospital (Baylor University Medical Center, Dallas, Tex) were retrieved and data abstracted in a predefined computerized database by a urology resident who was not part of the patient's surgical team. The abstracted data included attending surgeon, date of surgery, patient's age, clinical stage at presentation and pathologic stage, prostate-specific antigen (PSA), perioperative events, such as duration of surgery, blood loss, transfusion, duration of hospital stay, comorbidities according to the Charlson comorbidity index, and others. The data were analyzed in regard to changes over the 10-year period and stratified by a variety of parameters.
RESULTS: The number of radical prostatectomies performed increased by fourfold from 1984 to 1993. The distribution of clinical stage and the incidence of pathologic upstaging noted in the 428 cases were similar to other series reported in the literature. The average age of patients decreased from 67 to 63 years over the 10 years (average calculated in increments of 15 cases in ascending order). Similarly, over time the average duration of surgery, average blood loss, average use of transfusion, and the average duration of hospital stay decreased. When the cases were grouped by individual attending surgeon, whose numerical surgical experience during that time period ranged from 1 to 76 cases, no correlation was noted between the numerical experience and these outcomes.
CONCLUSIONS: As opposed to the national Medicare experience recently reported by the Prostate Patients Outcome Research Team, the increase in the number of cases performed was mostly due to patients under the age of 70 years, considered reasonable candidates for radical prostatectomy. Independent of numerical experience of individual attending surgeons, duration of surgery, blood loss, transfusion rates, and duration of hospital stay decreased during this period. This might indicate a learning effect due to continuing education, exchange of ideas, published technical improvements in the surgical procedure, and other factors, ultimately benefiting the patient by improving outcomes.

Entities:  

Mesh:

Year:  1995        PMID: 7747373     DOI: 10.1016/s0090-4295(99)80089-2

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

Review 1.  Prostate cancer: a comprehensive review.

Authors:  S N Pentyala; J Lee; K Hsieh; W C Waltzer; A Trocchia; L Musacchia; M J Rebecchi; S A Khan
Journal:  Med Oncol       Date:  2000-05       Impact factor: 3.064

2.  Variations in the quality of care at radical prostatectomy.

Authors:  Quoc-Dien Trinh; Jesse Sammon; Jay Jhaveri; Maxine Sun; Khurshid R Ghani; Jan Schmitges; Wooju Jeong; James O Peabody; Pierre I Karakiewicz; Mani Menon
Journal:  Ther Adv Urol       Date:  2012-04

Review 3.  Basic principles of anatomy for optimal surgical treatment of prostate cancer.

Authors:  Jochen Walz; Markus Graefen; Hartwig Huland
Journal:  World J Urol       Date:  2007-02-27       Impact factor: 4.226

Review 4.  Prostate cancer: 6. Surgical treatment of localized disease.

Authors:  S L Goldenberg; E W Ramsey; M A Jewett
Journal:  CMAJ       Date:  1998-11-17       Impact factor: 8.262

Review 5.  A systematic review of the volume-outcome relationship for radical prostatectomy.

Authors:  Quoc-Dien Trinh; Anders Bjartell; Stephen J Freedland; Brent K Hollenbeck; Jim C Hu; Shahrokh F Shariat; Maxine Sun; Andrew J Vickers
Journal:  Eur Urol       Date:  2013-04-19       Impact factor: 20.096

6.  Shift of tumor features in patients with clinically localized prostate cancer undergoing radical prostatectomy since the beginning of the PSA era.

Authors:  Herbert Augustin; Marco Auprich; Philipp Stummvoll; Katja Lipsky; Karl Pummer; Peter Petritsch
Journal:  Wien Klin Wochenschr       Date:  2006-06       Impact factor: 1.704

Review 7.  Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy.

Authors:  M C Beduschi; R Beduschi; J E Oesterling
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

8.  Impact of preoperative antiandrogen medication and nerve-sparing surgery on the outcome of radical prostatectomy.

Authors:  J Hodzic; P Jedrusik; T Reckwitz; H-J Knopf; K Golka
Journal:  Int Urol Nephrol       Date:  2008-04-10       Impact factor: 2.370

9.  Contemporary update of cancer control after radical prostatectomy in the UK.

Authors:  M H Winkler; F A Khan; M Shabir; A Okeke; M Sugiono; P McInerney; G B Boustead; R Persad; A V Kaisary; D A Gillatt
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.